Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amylin as a Future Obesity Treatment
Babak Dehestani, Nicholas RS Stratford, Carel W. le Roux
Journal of Obesity & Metabolic Syndrome (2021) Vol. 30, Iss. 4, pp. 320-325
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
Marlene Chakhtoura, Rachelle Haber, Malak Ghezzawi, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101882-101882
Open Access | Times Cited: 266
What is the pipeline for future medications for obesity?
Eka Melson, Uzma Ashraf, Dimitris Papamargaritis, et al.
International Journal of Obesity (2024)
Open Access | Times Cited: 112
Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
Rachel Sinha, Dimitris Papamargaritis, Jack A. Sargeant, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 1, pp. 25-45
Open Access | Times Cited: 62
New therapies for obesity
Dimitris Papamargaritis, Carel W. le Roux, Jens J. Holst, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 18, pp. 2825-2842
Open Access | Times Cited: 42
Pharmacologic Treatment of Obesity in Reproductive Aged Women
Akua Nuako, Lucy Tu, Karen J. Campoverde Reyes, et al.
Current Obstetrics and Gynecology Reports (2023) Vol. 12, Iss. 2, pp. 138-146
Open Access | Times Cited: 23
The role of amylin, a gut–brain axis hormone, in metabolic and neurological disorders
Tahir Muhammad, Stephen F. Pastore, Katrina Good, et al.
FASEB BioAdvances (2025)
Open Access | Times Cited: 1
Mediators of Amylin Action in Metabolic Control
Christina N. Boyle, Yi Zheng, Thomas A. Lutz
Journal of Clinical Medicine (2022) Vol. 11, Iss. 8, pp. 2207-2207
Open Access | Times Cited: 33
Future therapies for obesity
Eka Melson, Alexander D. Miras, Dimitris Papamargaritis
Clinical Medicine (2023) Vol. 23, Iss. 4, pp. 337-346
Open Access | Times Cited: 19
Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?
Prathima Gogineni, Eka Melson, Dimitris Papamargaritis, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 801-818
Open Access | Times Cited: 8
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity
Antonella M. D’Ascanio, Jamie Mullally, William H. Frishman
Cardiology in Review (2023) Vol. 32, Iss. 1, pp. 83-90
Closed Access | Times Cited: 13
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide Agonists
Peter Keov, George Christopoulos, Caroline A. Hick, et al.
Molecular Pharmacology (2024) Vol. 105, Iss. 5, pp. 359-373
Open Access | Times Cited: 5
Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management
Jang Won Son, Soo Lim
Endocrinology and Metabolism (2024) Vol. 39, Iss. 2, pp. 206-221
Open Access | Times Cited: 5
Future Perspectives in the Management of Obesity
Shilpa Chugh Garcha, Sanjay Kalra
(2025), pp. 121-154
Closed Access
The protective effect of amylin in type 2 diabetes: Yes or no
Mohammad Saud Alanazi, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
European Journal of Pharmacology (2025), pp. 177593-177593
Open Access
Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments
Mohsen Nabi‐Afjadi, S. Ostadhadi, Mahsa Liaghat, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116808-116808
Open Access | Times Cited: 3
Hyperglycemia-driven signaling bridges between diabetes and cancer
Somayyeh Ghareghomi, Payam Arghavani, Majid Mahdavi, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116450-116450
Closed Access | Times Cited: 3
Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis
Deep Dutta, Lakshmi Nagendra, BG Harish, et al.
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 5, pp. 436-444
Open Access | Times Cited: 3
HbA1c reduction strategies: An overview of pharmacological interventions
Krishna Upadhye, Hariom Patidar, Narendra Bamnia, et al.
National Journal of Pharmacology and Therapeutics (2025) Vol. 3, Iss. 1, pp. 24-33
Closed Access
Advancing Diabetes Management and Glycemic Control While Exploring CagriSema’s Impact on Obesity Management
Somar Hadid, William H. Frishman, Wilbert S. Aronow
Cardiology in Review (2025)
Closed Access
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity
Špela Volčanšek, Andrijana Koceva, Mojca Jensterle, et al.
Diabetes Therapy (2025)
Open Access
Nutrient-Based Appetite Regulation
Jose M. Moris, Corrinn Heinold, Alexandra Blades, et al.
Journal of Obesity & Metabolic Syndrome (2022) Vol. 31, Iss. 2, pp. 161-168
Open Access | Times Cited: 14
Gastric emptying in newly diagnosed, treatment‐naïve Han Chinese with type 2 diabetes and the impact of 4‐week insulin pump therapy
Yixuan Sun, Yong Luo, Chunjie Xiang, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 8, pp. 3078-3087
Open Access | Times Cited: 2
Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects
Igor Rubinić, Marija Kurtov, Robert Likić
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2
Amylin analogs for the treatment of obesity without diabetes: present and future
Theodoros Panou, Evanthia Gouveri, Djordje S. Popovic, et al.
Expert Review of Clinical Pharmacology (2024)
Closed Access | Times Cited: 2
Recent advancements in pharmacological strategies to modulate energy balance for combating obesity
Benudhara Pati, Satyabrata Sendh, Bijayashree Sahu, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 8, pp. 1429-1445
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top